The Scott R. MacKenzie Foundation is a family-based American philanthropic organization dedicated to funding leading-edge human genetic sequencing and research (DNA, RNA, protein) to advance cures for diseases such as cancer, lung disease, diabetes, and heart disease. It supports initiatives to identify and develop new treatment pathways through genome research, aiming to improve lives by advancing cures for specific diseases.
The MacKenzie Foundation Grant program focuses on funding genetic research with the broad goal of advancing cures for critical diseases including cancer, lung disease (including asthma), diabetes, and heart disease. It targets United States based tax-exempt organizations involved in genome research, such as medical schools, health systems, hospitals, and research entities. The Foundation prioritizes applicants that have been operational for more than five years and are committed to genome research related to the diagnosis, treatment, and cure of diseases. Additionally, it supports collaborative efforts that raise awareness about genome sequencing and research, aiming to inspire future generations and identify scientific researchers and centers of excellence dedicated to advancing research in genetic detection and treatment pathways.
While the Foundation is open to providing grants to any eligible beneficiary, it predominantly prefers to allocate funding towards initiatives that actively align with and contribute to the Foundation's core mission.